GuideNephrology
Risk of acute kidney injury or hyperkalaemia when starting an NSAID in older adults
Reading sheet on the Nash et al. model estimating 30-day risk of AKI or hyperkalaemia after starting an NSAID in people aged 66 or older.
Updated 3 November 2026
When to use it
People aged 66 or older being considered for an NSAID prescription, to individualise the decision and laboratory monitoring.
What it is
Population-based Ontario study (2007–2015) that matched 46,107 new NSAID users aged 66 or older with 46,107 non-users. NSAIDs were associated with more 30-day AKI (OR 1.41) and hyperkalaemia (OR 1.50; risk difference 0.23%), without increased mortality. A prediction model was built from these data.
Keep reading in the app
- Predictors
- Performance and interpretation
- Limitations
Practical tip
Mean absolute risk is low (AKI 0.82% vs 0.59% without NSAID at 30 days), but it concentrates in patients with low eGFR, high potassium and kidney-acting drugs.
2 more practical tips in the app.
Reference
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
